Advanced glycation end products in peripheral nerve in type 2 diabetes with neuropathy

Acta Diabetologica

Volumn 41, Issue 4, 2004, Pages 158-166

  Misur I ^a   Zarkovic K ^b   Barada, A ^a   Batelja, L ^c   Milicevic Z ^a   Turk, Z ^a  

^a University of Zagreb   (Croatia)

^b KBC Zagreb   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Advanced glycation endproducts; Diabetic polyneuropathy; Immunohistochemistry; Peripheral nerve

Indexed keywords

ADVANCED GLYCATION END PRODUCT; HEMOGLOBIN A1C;

ADULT; AGED; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIABETIC NEUROPATHY; DISEASE SEVERITY; ENDONEURIUM; FEMALE; FEMORAL NERVE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROVASCULATURE; MORPHOMETRICS; MYELIN SHEATH; NERVE FIBER; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PERINEURIUM; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; PRIORITY JOURNAL; SERUM; SPINAL ANESTHESIA; SURAL NERVE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY;

AGED; ANTIGEN-ANTIBODY COMPLEX; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMORAL NERVE; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MALE; MIDDLE AGED; SURAL NERVE;

EID: 12944298779     PISSN: 09405429     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00592-004-0160-0     Document Type: Article

References (22)

1. King RH (2001) The role of glycation in the pathogenesis of diabetic polyneuropathy. J Clin Pathol Mol Pathol 54:400-408
2. Cameron NE, Eaton SEM, Cotter MA, Tesfaye S (2001) Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 44:1973-1988
3. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986
4. The Diabetes Control and Complications Trial Research Group (1998) The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia 41:416-423
5. Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405-412
6. Carrington AL, Litchfield JE (1999) The aldose reductase pathway and nonenzymatic glycation in the pathogenesis of diabetic neuropathy: a critical review for the end of the 20th century. Diabetes Rev 4:275-299
7. Vlassara H, Bucala R, Striker L (1994) Pathogenic effects of AGEs: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 70:138-151
8. Ryle C, Donaghy M (1995) Non-enzymatic glycation of peripheral nerve proteins in human diabetics. J Neurol Sci 129:62-68
9. Sugimoto K, Nishizawa Y, Horiuchi S, Yagihashi S (1997) Localization in human diabetic peripheral nerve of N (epsilon)-carboxymethyl lysine-protein adducts, an advanced glycation endproduct. Diabetologia 40:1380-1387
10. Mišur I, Turk Z, Barada A, Miličević Z, Metelko Z (2001) Advanced glycation endproducts in human diabetic peripheral nerve. Diabetologia 44[Suppl 1]:A318
11. Thornalley PJ (1999) The clinical significance of glycation. Clin Lab 45:263-273
12. Turk Z, Mesič R, Benko B (1998) Comparison of advanced glycation endproducts on haemoglobin (Hb-AGE) and haemoglobin A1c for the assessment of diabetic control. Clin Chim Acta 277:159-170
13. Turk Z, Ljubic S, Turk N, Benko B (2001) Detection of autoantibodies against advanced glycation endproducts and AGE-immune complexes in serum of patients with diabetes mellitus. Clin Chim Acta 303:105-115
14. Jeppsson JO, Jerntorp P, Sundkvist G, Englund H, Nylund V (1986) Measurement of haemoglobin A1c by a new liquid-chromatographic assay: methodology, clinical utility, and relation to glucose tolerance evaluated. Clin Chem 32:1867-1872
15. Pascoe MK, Low PA, Windebank AJ, Litchy WJ (1997) Subacute diabetic proximal neuropathy. Mayo Clin Proc 72:1123-1132
16. Monnier VM, Sell DR, Nagaraj RH, Miyata S, Grandhee S, Odetti P, Ibrahim SA (1992) Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia. Diabetes 41[Suppl 2]:36-41
17. Turk Z, Mišur I, Turk N, Benko B (1999) Rat tissue collagen modified by advanced glycation: correlation with duration of diabetes and glycemic control. Clin Chem Lab Med 37:813-820
18. Vlassara H, Brownlee M, Cerami A (1983) Excessive non-enzymatic glycosylation of peripheral and central nervous system myelin components in diabetic rats. Diabetes 32:670-674
19. Ryle C, Leow CK, Donaghy M (1997) Nonenzymatic glycation of peripheral and central nervous system proteins in experimental diabetes mellitus. Muscle Nerve 20:577-584
20. Vlassara H, Brownlee M, Cerami A (1985) Recognition and uptake of human diabetic peripheral nerve myelin by macrophages. Diabetes 34:553-557
21. Morano S, Tiberti C, Cristina G, Sensi M, Cipriani R, Guidobaldi L, Torresi P, Medici F, Anastasi E, DiMario U (1999) Autoimmune markers and neurological complications in non-insulin-dependent diabetes mellitus. Hum Immunol 60:848-854
22. Turk Z, Šesto M, Skodlar J, Ferenčak G, Pokupec R, Turk N, Stavljenić-Rukavina A (2003) The products of advanced glycation in patients with type 2 diabetes and vascular disease. Ann Clin Biochem 40:552-559